RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
An experimental study of nicotine warning statements in ecigarette tweets
Guillory, J., Kim, A. E., Fiacco, L., Cress, M., Pepper, J., & Nonnemaker, J. (2020). An experimental study of nicotine warning statements in ecigarette tweets. Nicotine and Tobacco Research, (5), Article ntz029. https://doi.org/10.1093/ntr/ntz029
INTRODUCTION: t is unclear whether FDA's required warnings on e-cigarette advertisements will apply to social media. Given the key role of social media in marketing e-cigarettes, we seek to inform FDA decision-making by exploring how warnings on various tweet content influence perceived healthiness, nicotine harm, likelihood to try ecigarettes and warning recall.
METHODS: n this 2x4 between-subjects experiment participants viewed a tweet from a fictitious e-cigarette brand. Four tweet content versions (ecigarette product, ecigarette use, ecigarette in social context, unrelated content) were crossed with 2 warning versions (absent, present). Adult ecigarette users (n= 994) were recruited via social media ads to complete a survey and randomized to view one of 8 tweets. Multivariable regressions explored effects of tweet content and warning on perceived healthiness, perceived harm, and likelihood to try e-cigarettes and tweet content on warning recall. Covariates were tobacco and social media use and demographics.
RESULTS: Tweets with warnings elicited more negative health perceptions of the e-cigarette brand than tweets without warnings (p< 0.05). Tweets featuring ecigarette products (p< 0.05) or use (p< 0.001) elicited higher warning recall than tweets featuring unrelated content.
CONCLUSIONS: his is the first study to examine warning effects on perceptions of e-cigarette social media marketing. Warnings led to more negative e-cigarette health perceptions, but no effect on perceived nicotine harm or likelihood to try e-cigarettes. There were differences in warning recall by tweet content. Research should explore how varying warning content (text, size, placement) on tweets from e-cigarette brands influences health risk perceptions.
IMPLICATIONS: FDA's 2016 ruling requires warnings on advertisements for nicotine-containing e-cigarettes, but does not specify whether this applies to social media. This study is the first to examine how e-cigarette warnings in tweets influence perceived healthiness and harm of e-cigarettes, which is important because e-cigarette brands are voluntarily including warnings on Twitter and Instagram. Warnings influenced perceived healthiness of the e-cigarette brand, but not perceived nicotine harm or likelihood to try e-cigarettes. We also saw higher recall of warning statements for tweets featuring e-cigarettes. Findings suggest that expanding warning requirements to e-cigarette social media marketing warrants further exploration and FDA consideration.